ADCETRIS
- Product NDC
- 51144-050
- 11-digit product format
- 511440050
- Labeler code
- 51144
- Product ID
- 51144-050_a695c1a2-3acc-468b-a829-c8761dc041f6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- brentuximab vedotin
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- SEAGEN INC.
- Application
- BLA125388
- Marketing category
- BLA
- Marketing start
- 2011-08-25
- Substance
- BRENTUXIMAB VEDOTIN
- Active strength
- 50 mg/10.5mL
- Pharmacologic classes
- CD30-directed Antibody Interactions [MoA], CD30-directed Immunoconjugate [EPC], Immunoconjugates [CS], Microtubule Inhibition [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ADCETRIS
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BRENTUXIMAB VEDOTIN | 50 mg/10.5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7XL5ISS668 |
| Rxcui | 1147323, 1147327 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51144-050-01 | ADCETRIS | 1 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 1 | | 38 |
| 51144-050-01 | ADCETRIS | 10.5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 10.5 | | 38 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Brentuximab Vedotin | ACTIVE INGREDIENT | 7XL5ISS668 | ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] | 15 | |
| Brentuximab Vedotin | ACTIVE MOIETY | 7XL5ISS668 | ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] | 15 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] | 15 | |
| Polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] | 15 | |
| Trehalose Dihydrate | INACTIVE INGREDIENT | 7YIN7J07X4 | ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] | 15 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] | 15 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51144-050 | ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEAGEN INC.] | 36 | Current NDC, Legacy NDC, 2 package rows | 20250221_3904f8dd-1aef-3490-e48f-bd55f32ed67f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51144-050-01 | 51144005001 | 1 VIAL, SINGLE-DOSE in 1 BOX (51144-050-01) / 10.5 mL in 1 VIAL, SINGLE-DOSE | 2011-08-25 | 0000-00-00 | No | No | Current |